DI BARTOLOMEO, MARIA CRISTINA

DI BARTOLOMEO, MARIA CRISTINA  

Mostra records
Risultati 1 - 16 di 16 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study 2022 Raimondi, AlessandraPrisciandaro, MicheleSartore-Bianchi, AndreaDi Bartolomeo, Mariade Braud, FilippoPietrantonio, Filippo + Article (author) -
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series 2022 Ambrosini, MargheritaManca, PaoloRandon, GiovanniSartore-Bianchi, AndreaDi Bartolomeo, MariaPietrantonio, Filippo + Article (author) -
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study 2021 Toscano G.Tomasello G.Petrelli F.Prisciandaro M.Randon G.de Braud F.Di Bartolomeo M.Pietrantonio F. + Article (author) -
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer 2021 Manca P.Corallo S.Randon G.Tomasello G.Prisciandaro M.Di Bartolomeo M.de Braud F.Pietrantonio F. + Article (author) -
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors 2021 Corti, FrancescaAmbrosini, MargheritaManca, PaoloRaimondi, AlessandraPrisciandaro, MicheleCurigliano, GiuseppeDe Braud, FilippoDi Bartolomeo, MariaPietrantonio, Filippo + Article (author) -
Maintenance Therapy with Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 2019 Pietrantonio, FilippoRaimondi, AlessandraSartore-Bianchi, AndreaNiger, MonicaPetrelli, FaustoLongarini, RaffaellaDi Bartolomeo, Mariade Braud, Filippo + Article (author) -
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases 2019 F. PietrantonioC. CotsoglouG. FucàF. NichettiJ. CoppaA. AlessiM. PrisciandaroM. Droz-Dit BussetS. CoralloA. MennittoG. RandonA. RaimondiB. PadovanoF. PerroneM. Di BartolomeoF. de BraudV. Mazzaferro + Article (author) -
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions 2017 Pietrantonio, FilippoCotsoglou, ChristianInfante, GabrieleCoppa, JorgelinaPadovano, BarbaraMennitto, AlessiaNiger, MonicaFucà, GiovanniLazzati, SilviaGreco, GiorgioDelconte, GabrieleDe Braud, FilippoMazzaferro, VincenzoDi Bartolomeo, Maria + Article (author) -
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 2017 Vernieri, ClaudioVolpi, Chiara CostanzaNiger, MonicaValtorta, EmanueleFucà, GiovanniDi Bartolomeo, MariaDe Braud, FilippoPietrantonio, Filippo + Article (author) -
Transcriptional and epigenetic phenomena in peripheral blood cells of monozygotic twins discordant for Alzheimer’s disease, a case report 2017 B. ArosioM. Di BartolomeoA. CasèS. DamantiL..C. BergamaschiniD. Mari + Article (author) -
Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer : a systematic review and meta-analysis 2017 F. PetrelliTURATI, LUCAA. MennittoF. de BraudM. Di BartolomeoV. MazzaferroF. Pietrantonio + Article (author) -
Single-agent panitumumab in frail elderly patients with advanced RAS and BRAF wild-type colorectal cancer : challenging drug label to light up new hope 2015 F. PietrantonioA. MennittoR. LongariniM. Di BartolomeoF. De Braud + Article (author) -
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer : a systematic review and meta-analysis 2015 F. PietrantonioF. PetrelliM. Di BartolomeoC. MaggiF. de Braud + Article (author) -
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan 2015 F.S. FalvellaS. CheliC. MazzaliC. MaggiM. Di BartolomeoI. BossiF. de BraudE. ClementiF. Pietrantonio + Article (author) -
A review on biomarkers for prediction of treatment outcome in gastric cancer 2013 F. PietrantonioF. De BraudG. FanettiP. BiondaniM. Di Bartolomeo + Article (author) -
Bax expression is predictive of favorable clinical outcome in chemonaive advanced gastric cancer patients treated with capecitabine, oxaliplatin, and irinotecan regimen 2012 Pietrantonio, FilippoBiondani, Pamelade Braud, FilippoBIANCHINI, GIANPAOLODi Bartolomeo, Maria + Article (author) -